Related Experiment Video
Updated: May 27, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes
Thati Madhusudhan1, Hongjie Wang, Beate K Straub
1Department of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, Germany.
Insights
Activated protein C (aPC) protects kidney podocytes via a novel signaling pathway involving protease-activated receptor-3 (PAR-3) and PAR-2/PAR-1. This mechanism inhibits apoptosis and reduces kidney injury.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Signaling
Background:
- Activated protein C (aPC) exhibits cytoprotective effects, but its signaling mechanisms in kidney podocytes are undefined.
- Existing knowledge indicates aPC protects glomerular endothelial cells via PAR-1 and EPCR, but podocyte-specific pathways remain elusive.
Purpose of the Study:
- To elucidate the signaling mechanism by which aPC confers cytoprotection to podocytes.
- To identify the specific receptors and pathways involved in aPC-mediated podocyte protection.
Main Methods:
- Investigated aPC signaling in podocytes using biochemical assays and genetic manipulation.
- Examined aPC-induced activation of protease-activated receptors (PARs) and their downstream effects.
- Assessed the role of PAR-3, PAR-2, PAR-1, and caveolin-1 in aPC-mediated cytoprotection.
- Evaluated the in vivo effects of aPC in a mouse model of podocyte injury.
Main Results:
- Identified a novel aPC/PAR-dependent cytoprotective signaling mechanism in podocytes.
- aPC inhibits podocyte apoptosis via proteolytic activation of PAR-3, independent of EPCR.
- PAR-3 requires aPC-induced heterodimerization with PAR-2 (human) or PAR-1 (mouse) to signal.
- This pathway involves caveolin-1 dephosphorylation and confers protection against LPS-induced podocyte injury and proteinuria in vivo.
- Genetic deletion of PAR-3 abrogated the nephroprotective effects of aPC.
Conclusions:
- Discovered a novel, cell-specific signaling mechanism for aPC in kidney podocytes involving PAR-3 and PAR-2/PAR-1 heterodimerization.
- This pathway highlights the plasticity of aPC signaling and its dependence on specific receptor interactions.
- Findings suggest potential for developing targeted therapies for kidney diseases based on these specific signaling complexes.
Abstract:
The cytoprotective effects of activated protein C (aPC) are well established. In contrast, the receptors and signaling mechanism through which aPC conveys cytoprotection in various cell types remain incompletely defined. Thus, within the renal glomeruli, aPC preserves endothelial cells via a protease-activated receptor-1 (PAR-1) and endothelial protein C receptor-dependent mechanism. Conversely, the signaling mechanism through which aPC protects podocytes remains unknown. While exploring the latter, we identified a novel aPC/PAR-dependent cytoprotective signaling mechanism. In podocytes, aPC inhibits apoptosis through proteolytic activation of PAR-3 independent of endothelial protein C receptor. PAR-3 is not signaling competent itself as it requires aPC-induced heterodimerization with PAR-2 (human podocytes) or PAR-1 (mouse podocytes). This cytoprotective signaling mechanism depends on caveolin-1 dephosphorylation. In vivo aPC protects against lipopolysaccharide-induced podocyte injury and proteinuria. Genetic deletion of PAR-3 impairs the nephroprotective effect of aPC, demonstrating the crucial role of PAR-3 for aPC-dependent podocyte protection. This novel, aPC-mediated interaction of PARs demonstrates the plasticity and cell-specificity of cytoprotective aPC signaling. The evidence of specific, dynamic signaling complexes underlying aPC-mediated cytoprotection may allow the design of cell type specific targeted therapies.
Related Concept Videos
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Endocrine Signaling
The Extrinsic Apoptotic Pathway
Caspases

